Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chinook Therapeutics Inc (NQ: KDNY ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chinook Therapeutics Inc < Previous 1 2 3 4 Next > INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm May 16, 2023 From The Schall Law Firm Via Business Wire KDNY INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Chinook Therapeutics, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – KDNY May 16, 2023 From The Rosen Law Firm, P.A. Via Business Wire Where Chinook Therapeutics Stands With Analysts May 10, 2023 Via Benzinga Recap: Chinook Therapeutics Q1 Earnings May 09, 2023 Via Benzinga Chinook Therapeutics Trial Pause: Unfortunate But Analyst Reassures No Damage To Value Drivers April 11, 2023 Via Benzinga Chinook Therapeutics Earnings Perspective: Return On Capital Employed March 03, 2023 Via Benzinga Where Chinook Therapeutics Stands With Analysts February 28, 2023 Via Benzinga Chinook Therapeutics's Return On Capital Employed Insights December 22, 2022 Via Benzinga Chinook's Kidney Disease Candidate Continues To Show Rapid, Sustained Reductions In Biomarkers May 19, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023 March 06, 2023 Via Benzinga Analyst Views Multiple Opportunities For Chinook To Thrive In Emerging Renal Markets, Sees More Than 100% Upside March 01, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 March 01, 2023 Via Benzinga Why Vera Stock Crashed 60% On Its 'Positive' Kidney Drug Update — And Chinook Popped January 04, 2023 The "devil is in the details" when it comes to comparing data across studies. Via Investor's Business Daily 20 Favorite Biotech & Medical Stocks For 2023 December 28, 2022 The way these stocks are setting up, many of them look great and will be at the forefront this coming year. Via Talk Markets Have A Look At William Blair's Top Biotech Picks For 2023 December 25, 2022 William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period. Via Benzinga 7 Cheap Biotech Stocks to Buy Now August 03, 2022 These cheap biotech stocks to buy offer investors a way to get ready for the inevitable comeback in the biopharmaceutical sector. Via InvestorPlace Chinook Secures Orphan Drug Status From European Commission For Kidney Disease Drug July 05, 2022 Chinook Therapeutics, Inc. (NASDAQ: KDNY) announced that the European Commission has granted orphan drug designation for BION-1301 for the treatment of primary IgA nephropathy (IgAN). Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022 December 05, 2022 Via Benzinga The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study July 05, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022 June 28, 2022 Upgrades Via Benzinga The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine May 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 88 Biggest Movers From Yesterday May 26, 2022 Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw... Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session May 25, 2022 Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies. Via Benzinga 21 Stocks Moving in Wednesday's Pre-Market Session May 25, 2022 Gainers The Singing Machine Company, Inc. (NASDAQ: MICS) shares rose 47.3% to $4.05 in pre-market trading. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session May 24, 2022 Gainers Via Benzinga The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara May 20, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session May 19, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for... Via Benzinga 71 Biggest Movers From Yesterday May 20, 2022 Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... Via Benzinga The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate May 19, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session March 15, 2022 Gainers Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.